A functional variant in ANGPT1 and the risk of pregnancies with hypertensive disorders and small-for-gestational-age infants

Molecular Human Reproduction

Volumn 18, Issue 6, 2012, Pages 325-332

  Andraweera, Prabha H ^a,b   Dekker, Gustaaf A ^a,c   Thompson, Steven D ^a   North, Robyn A ^d   McCowan, Lesley M E ^e   Roberts, Claire T ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF COLOMBO   (Sri Lanka)

^c LYELL MCEWIN HOSPITAL   (Australia)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

ANGPT1; Polymorphism; Pre eclampsia; SGA infants

Indexed keywords

ANGIOPOIETIN 1; THYMINE;

ADULT; ANGPT1 GENE; ARTERY RESISTANCE; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DOPPLER FLOWMETRY; FEMALE; FETOMATERNAL TRANSFUSION; GENE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PREECLAMPSIA; PREVALENCE; PRIORITY JOURNAL; RISK; SMALL FOR DATE INFANT; UTERINE ARTERY;

ADULT; ANGIOPOIETIN-1; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; MALE; NEW ZEALAND; PLACENTA DISEASES; POLYMORPHISM, SINGLE NUCLEOTIDE; PRE-ECLAMPSIA; PREGNANCY; PROSPECTIVE STUDIES; RISK; SOUTH AUSTRALIA; UTERINE ARTERY; YOUNG ADULT;

EID: 84861751153     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gar081     Document Type: Article

References (28)

1. Andraweera PH, Dekker GA, Thompson SD, North RA, McCowan LM, Roberts CT. A functional variant in the thrombospondin-1 gene and the risk of small for gestational age infants. J Thromb Haemost 2011; 9:2221-2228.
2. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001; 125:279-284.
3. Bolin M, Wiberg-Itzel E, Wikstrom AK, Goop M, Larsson A, Olovsson M, Akerud H. Angiopoietin-1/angiopoietin-2 ratio for prediction of preeclampsia. Am J Hypertens 2009;22:891-895.
4. Bushnell C, Chireau M. Preeclampsia and stroke: risks during and after pregnancy. Stroke Res Treat 2011;2011:858134.
5. Chambers JC, Fusi L, Malik IS, Haskard DO, De Swiet M, Kooner JS. Association of maternal endothelial dysfunction with preeclampsia. J Am Med Assoc 2001;285:1607-1612.
6. Chen C-P, Bajoria R, Aplin JD. Decreased vascularization and cell proliferation in placentas of intrauterine growth-restricted fetuses with abnormal umbilical artery flow velocity waveforms. Am J Obstet Gynecol 2002;187:764-769.
7. Chen J, Yang T, Yu H, Sun K, Shi Y, SongW, Bai Y, Wang X, Lou K, Song Y et al. A functional variant in the 3'-UTR of angiopoietin-1 might reduce stroke risk by interfering with the binding efficiency of microRNA 211. Hum Mol Genet 2010;19:2524-2533.
8. Deurloo KL, Bolte AC, Twisk JW, van Vugt JM. Longitudinal Doppler measurements of spiral artery blood flow in relation to uterine artery blood flow. J Ultrasound Med 2009;28:1623-1628.
9. Dunk C, Shams M, Nijjar S, Rhaman M, Qiu Y, Bussolati B, Ahmed A. Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development. Am J Pathol 2000;156:2185-2199.
10. Geva E, Ginzinger DG, Zaloudek CJ, Moore DH, Byrne A, Jaffe RB. Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2. J Clin Endocrinol Metab 2002;87:4213-4224.
11. Groom KM, North RA, Stone PR, Chan EH, Taylor RS, Dekker GA, McCowan LM. Patterns of change in uterine artery Doppler studies between 20 and 24 weeks of gestation and pregnancy outcomes. Obstet Gynecol 2009;113:332-338.
12. Hindle AK, Edwards C, McCaffrey T, Fu S, Brody F. Identification of cardiovascular genes in omentum from morbidly obese patients with type 2 diabetes. Int J Obes (Lond) 2010;34:1020-1027.
13. Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol 2011;25:391-403.
14. Khong Y, Brosens I. Defective deep placentation. Best Pract Res Clin Obstet Gynaecol 2011;25:301-311.
15. Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986;93:1049-1059.
16. Mayhew TM, Charnock-Jones DS, Kaufmann P. Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies. Placenta 2004;25:127-139.
17. McCowan L, Stewart AW, Francis A, Gardosi J. A customised birthweight centile calculator developed for a New Zealand population. Aust NZ J Obstet Gynaecol 2004;44:428-431.
18. McCowan LM, Roberts CT, Dekker GA, Taylor RS, Chan EH, Kenny LC, Baker PN, Moss-Morris R, Chappell LC, North RA. Risk factors for small-for-gestational-age infants by customised birthweight centiles: data from an international prospective cohort study. BJOG 2010; 117:1599-1607.
19. McCowan LM, North RA, Kho EM, Black MA, Chan EH, Dekker GA, Poston L, Taylor RS, Roberts CT. Paternal contribution to small for gestational age babies: a multicenter prospective study. Obesity (Silver Spring) 2011;19:1035-1039.
20. McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J 2008;156:918-930.
21. North RA, McCowan LM, Dekker GA, Poston L, Chan EH, Stewart AW, Black MA, Taylor RS, Walker JJ, Baker PN et al. Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort. Br Med J 2011;342:d1875.
22. Pons M, Marin-Castano ME. Cigarette smoke-related hydroquinone dysregulates MCP-1, VEGF and PEDF expression in retinal pigment epithelium in vitro and in vivo. PLoS One 2011;6:e16722.
23. Schiessl B, Innes BA, Bulmer JN, Otun HA, Chadwick TJ, Robson SC, Lash GE. Localization of angiogenic growth factors and their receptors in the human placental bed throughout normal human pregnancy. Placenta 2009;30:79-87.
24. Seval Y, Sati L, Celik-Ozenci C, Taskin O, Demir R. The distribution of angiopoietin-1, angiopoietin-2 and their receptors Tie-1 and Tie-2 in the very early human placenta. Placenta 2008;29:809-815.
25. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005; 365:785-799.
26. Sullivan KM, Mannucci A, Kimpton CP, Gill P. A rapid and quantitative DNA sex test: fluorescence-based PCR analysis of X-Y homologous gene amelogenin. Biotechniques 1993;15:636-638, 640-641.
27. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996; 87:1171-1180.
28. Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, Croll SD, Glazer N, Holash J, McDonald DM, Yancopoulos GD. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 2000; 6:460-463.